| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114643 | Autoimmunity Reviews | 2012 | 6 Pages |
Abstract
⺠There is an urgent need for alternatives to anti-TNF drugs in Crohn's disease (CD). ⺠IVIG has been used in CD for years, although few data, and no RCTS, are published. ⺠A literature review shows that IVIG can induce rapid improvement in CD within days. ⺠Longer-term data show that maintenance of remission over the medium term is possible. ⺠Verification is needed from large RCTs to show the safety and efficacy of IVIG in CD.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Moshe Rogosnitzky, Rachel Danks, Daniel Holt,